JPH0365351B2 - - Google Patents
Info
- Publication number
- JPH0365351B2 JPH0365351B2 JP58036211A JP3621183A JPH0365351B2 JP H0365351 B2 JPH0365351 B2 JP H0365351B2 JP 58036211 A JP58036211 A JP 58036211A JP 3621183 A JP3621183 A JP 3621183A JP H0365351 B2 JPH0365351 B2 JP H0365351B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- dihydropyridine
- dimethyl
- carboxylic acid
- nitrophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58036211A JPS59161392A (ja) | 1983-03-04 | 1983-03-04 | ジヒドロピリジン誘導体及びその製法 |
| GB08404386A GB2140015B (en) | 1983-03-04 | 1984-02-20 | Derivatives of dihydropyridine and production thereof |
| DE8484102249T DE3479582D1 (en) | 1983-03-04 | 1984-03-02 | Derivatives of dihydropyridine and production thereof |
| EP84102249A EP0121117B1 (en) | 1983-03-04 | 1984-03-02 | Derivatives of dihydropyridine and production thereof |
| ES530248A ES8505379A1 (es) | 1983-03-04 | 1984-03-02 | Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos |
| CA000448718A CA1254206A (en) | 1983-03-04 | 1984-03-02 | Derivatives of dihydropyridine and production thereof |
| US06/585,574 US4535073A (en) | 1983-03-04 | 1984-03-02 | Antihypertensive phosphono derivatives of hantzsch dihydropyridines |
| KR1019840001072A KR840007882A (ko) | 1983-03-04 | 1984-03-03 | 디히드로피리딘 유도체 및 그 제법 |
| ES537717A ES537717A0 (es) | 1983-03-04 | 1984-11-16 | Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58036211A JPS59161392A (ja) | 1983-03-04 | 1983-03-04 | ジヒドロピリジン誘導体及びその製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59161392A JPS59161392A (ja) | 1984-09-12 |
| JPH0365351B2 true JPH0365351B2 (enExample) | 1991-10-11 |
Family
ID=12463415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58036211A Granted JPS59161392A (ja) | 1983-03-04 | 1983-03-04 | ジヒドロピリジン誘導体及びその製法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4535073A (enExample) |
| EP (1) | EP0121117B1 (enExample) |
| JP (1) | JPS59161392A (enExample) |
| KR (1) | KR840007882A (enExample) |
| CA (1) | CA1254206A (enExample) |
| DE (1) | DE3479582D1 (enExample) |
| ES (2) | ES8505379A1 (enExample) |
| GB (1) | GB2140015B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6069089A (ja) * | 1983-09-26 | 1985-04-19 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホネ−ト誘導体およびその製造法 |
| CA1339372C (en) * | 1983-09-26 | 1997-08-26 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic ester |
| JPS6130591A (ja) * | 1984-07-20 | 1986-02-12 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホネ−ト誘導体 |
| EP0141221A1 (en) * | 1983-09-26 | 1985-05-15 | Nissan Chemical Industries Ltd. | 1,4-Dihydropyridine-5-phosphonic acid ester |
| JPS60248693A (ja) * | 1984-04-19 | 1985-12-09 | Nippon Shinyaku Co Ltd | ピリジン誘導体及び製法 |
| JPS6127995A (ja) * | 1984-07-18 | 1986-02-07 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホン酸モノエステル誘導体およびその製造法 |
| IT1201444B (it) * | 1985-08-01 | 1989-02-02 | Boehringer Biochemia Srl | Fosfonopiridine a loro 1,4-diidroderivati |
| IT1215298B (it) * | 1985-08-06 | 1990-01-31 | Boehringer Biochemia Srl | 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione. |
| US4885284A (en) * | 1986-01-22 | 1989-12-05 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
| CN1016063B (zh) | 1986-01-22 | 1992-04-01 | 日产化学工业株式会社 | 二氢吡啶-5-膦酸环亚丙基酯的制备 |
| JPH0699458B2 (ja) * | 1986-01-23 | 1994-12-07 | 日産化学工業株式会社 | ジヒドロピリジン−5−ホスホン酸環状エステル類 |
| JPS63115890A (ja) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | 2位置換1,4−ジヒドロピリジン誘導体 |
| US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
| JP2850376B2 (ja) * | 1988-08-02 | 1999-01-27 | 日産化学工業株式会社 | 抗癌剤薬効増強剤 |
| ATE128623T1 (de) * | 1988-08-02 | 1995-10-15 | Nissan Chemical Ind Ltd | Mittel zur verbesserung von arzneimitteleffekten für antitumormittel. |
| RU2326886C2 (ru) | 2003-03-28 | 2008-06-20 | Ниссан Кемикал Индастриз, Лтд. | Блокатор кальциевых каналов т-типа |
| JP6017964B2 (ja) | 2010-03-01 | 2016-11-02 | ティーエーユー・セラピューティクス・エルエルシー | 癌診断および撮像 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
-
1983
- 1983-03-04 JP JP58036211A patent/JPS59161392A/ja active Granted
-
1984
- 1984-02-20 GB GB08404386A patent/GB2140015B/en not_active Expired
- 1984-03-02 CA CA000448718A patent/CA1254206A/en not_active Expired
- 1984-03-02 ES ES530248A patent/ES8505379A1/es not_active Expired
- 1984-03-02 US US06/585,574 patent/US4535073A/en not_active Expired - Fee Related
- 1984-03-02 DE DE8484102249T patent/DE3479582D1/de not_active Expired
- 1984-03-02 EP EP84102249A patent/EP0121117B1/en not_active Expired
- 1984-03-03 KR KR1019840001072A patent/KR840007882A/ko not_active Ceased
- 1984-11-16 ES ES537717A patent/ES537717A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB2140015A (en) | 1984-11-21 |
| ES8603902A1 (es) | 1986-01-01 |
| DE3479582D1 (en) | 1989-10-05 |
| ES530248A0 (es) | 1985-05-16 |
| KR840007882A (ko) | 1984-12-11 |
| ES537717A0 (es) | 1986-01-01 |
| CA1254206A (en) | 1989-05-16 |
| EP0121117A1 (en) | 1984-10-10 |
| GB8404386D0 (en) | 1984-03-28 |
| US4535073A (en) | 1985-08-13 |
| GB2140015B (en) | 1987-07-29 |
| JPS59161392A (ja) | 1984-09-12 |
| ES8505379A1 (es) | 1985-05-16 |
| EP0121117B1 (en) | 1989-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0365351B2 (enExample) | ||
| KR100543614B1 (ko) | 4-페닐피페리딘 화합물 | |
| EP0089167B1 (en) | Dihydropyridine anti-ischaemic and antihypertensive agents, processes for their production, and pharmaceutical compositions containing them | |
| RU2114855C1 (ru) | Производные гуанидиналкил-1,1-бис-фосфоновых кислот и способ их получения | |
| EP1216996A2 (fr) | Procédé de préparation de dérives biphenylyl | |
| CA1320204C (en) | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters | |
| PT842170E (pt) | Derivados de difenilmetilenopiperidina | |
| WO1994013291A1 (en) | Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives | |
| DE69824450T2 (de) | Biphenylamidin-derivate | |
| KR870001537B1 (ko) | 페닐지방성 카복실린산유도체의 제조방법 | |
| US4983740A (en) | Process for 1,4-dihydropyridine compounds | |
| RU2055834C1 (ru) | Производные (бензгидрилоксиэтилпиперидил)алифатической кислоты или их фармацевтически приемлемые кислотно-аддитивные соли | |
| JP3158638B2 (ja) | 新規アミノフェノール誘導体及びその医薬用途 | |
| FR2662442A1 (fr) | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. | |
| JP3280040B2 (ja) | アミノベンゼン化合物 | |
| FR2549058A1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments | |
| US4870091A (en) | 1,4-dihydropyridine compounds | |
| JP2640245B2 (ja) | 1,4−ジヒドロピリジン誘導体 | |
| KR101720060B1 (ko) | 비닐 설폰 유도체, 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 포함하는 시신경 척추염 예방 또는 치료용 약학조성물 | |
| US3766245A (en) | 3,5-dialkoxyalkoxy-4-substituted benzoic acid esters | |
| EP0663395B1 (de) | 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als herzfrequenzsenkendes Mittel | |
| JPS6352031B2 (enExample) | ||
| EP0220917B1 (en) | 1,4-dihydropyridine pharmaceutical derivatives and their salts, and the preparation thereof | |
| US2570286A (en) | Tertiary-amino-2-aryl-2-(4-quinolyl) alkane-nitriles and their preparation | |
| US4675329A (en) | Isopropyl 2-(3-trifluoromethylphenoxy)-ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate as vaso-dilators |